Your browser doesn't support javascript.
loading
Viral infections and immune reconstitution interaction after pediatric allogenic hematopoietic stem cell transplantation.
Alexandersson, Adam; Koskenvuo, Minna; Tiderman, Anette; Lääperi, Mitja; Huttunen, Pasi; Saarinen-Pihkala, Ulla; Anttila, Veli-Jukka; Lautenschlager, Irmeli; Taskinen, Mervi.
Afiliação
  • Alexandersson A; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, New Children's Hospital, Helsinki University Hospital , Helsinki , Finland.
  • Koskenvuo M; Faculty of Medicine, University of Helsinki , Helsinki , Finland.
  • Tiderman A; New Children's Hospital, Pediatric Research Center, University of Helsinki, Helsinki University Hospital , Helsinki , Finland.
  • Lääperi M; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, New Children's Hospital, Helsinki University Hospital , Helsinki , Finland.
  • Huttunen P; Faculty of Medicine, University of Helsinki , Helsinki , Finland.
  • Saarinen-Pihkala U; Faculty of Medicine, University of Helsinki , Helsinki , Finland.
  • Anttila VJ; New Children's Hospital, Pediatric Research Center, University of Helsinki, Helsinki University Hospital , Helsinki , Finland.
  • Lautenschlager I; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, New Children's Hospital, Helsinki University Hospital , Helsinki , Finland.
  • Taskinen M; Faculty of Medicine, University of Helsinki , Helsinki , Finland.
Infect Dis (Lond) ; 51(10): 772-778, 2019 10.
Article em En | MEDLINE | ID: mdl-31380705
ABSTRACT

Background:

Viral infections are a major cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Although immune suppression plays a central role, the literature shows conflicting results on interplay between post-transplant immune reconstitution (IR) and viral infections.

Methods:

We prospectively studied viral infections and IR in 30 pediatric patients undergoing allogenic HSCT, with a follow-up time of 24 months. In total, 1337 blood (CMV, EBV, HHV-6, ADV and BKV) and urine (BKV and JCV) virus samples were analyzed. IR including B-cells (CD19+), T cells (CD3+, CD4+, CD8+) and NK-cells were measured. Clinical outcomes included overall survival (OS), non-relapse mortality (NRM), graft-versus-host disease (GVHD) and occurrence of blood culture positive bacterial infections.

Results:

We found BKV reactivation to be most frequent, 47% of the children had viremia and 77% viruria. The frequencies of CMV, HHV-6 and adeno viremia were 37%, 37% and 6%, respectively. Viremias beyond 3 months post-HSCT were uncommon. Factors such as GVHD, use of steroids, EBV and CMV infections and pre-transplant irradiation affected IR. No specific viral infection or IR related factor was associated to OS or NRM.

Conclusions:

Viral infections and IR interact in a bi-directional manner. Accordingly, close follow-up of both IR and viral loads is warranted.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Vírus / Viroses / Transplante de Células-Tronco Hematopoéticas Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Vírus / Viroses / Transplante de Células-Tronco Hematopoéticas Idioma: En Ano de publicação: 2019 Tipo de documento: Article